Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sue Langham"'
Autor:
Heide A. Stirnadel-Farrant, Sarowar M. Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham, Sue Langham, Mihail Samnaliev
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1183-1197 (2023)
Abstract Introduction This analysis compared healthcare resource use (HCRU) and costs associated with incident organ damage in a cohort of adult patients with systemic lupus erythematosus (SLE). Methods Incident SLE cases were identified (Clinical Pr
Externí odkaz:
https://doaj.org/article/225ac143668d4ac5a190ba3d0c663488
Autor:
Heide A. Stirnadel-Farrant, Sarowar M. Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham, Sue Langham, Mihail Samnaliev
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1167-1182 (2023)
Abstract Introduction This analysis was conducted to assess the incidence of adverse clinical outcomes, healthcare resource use (HCRU), and the costs associated with systemic corticosteroid (SCS) use in adults with systemic lupus erythematosus (SLE)
Externí odkaz:
https://doaj.org/article/51fd9ce8e6404aaebeea68995f80f682
Autor:
Christer Janson, Jaime Hernando Platz, Stéphane Soulard, Sue Langham, Lindsay Nicholson, Elisabeth Sophia Hartgers-Gubbels
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Objective Inhalation therapy is the cornerstone of COPD, together with non-pharmacological treatments. Long-acting muscarinic antagonists (LAMAs), alone or in combination with long-acting β-agonists (LABAs), are commonly used. Pressurised metered-do
Externí odkaz:
https://doaj.org/article/d464508e8fa34378ac6376ffd3ba97c0
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Despite conventional treatment, a proportion of interstitial lung disease (ILD) patients develop a progressive phenotype known as “fibrosing ILD with a progressive phenotype” (PF-ILD), characterized by worsening respiratory symptoms, decline in l
Externí odkaz:
https://doaj.org/article/c1c6add97e1447efa01a27d2c1bbc4cc
Autor:
Sue Langham, Jen Lewis, Nick Pooley, Nina Embleton, Julia Langham, MeiLan K. Han, James D. Chalmers
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-13 (2019)
Abstract Background Guidelines recommend that treatment with a long-acting β2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), and inhaled corticosteroids (ICS), i.e. triple therapy, is reserved for a select group of symptomatic patients
Externí odkaz:
https://doaj.org/article/8723e4ca12104b79ab3f59198e8adb9f
Publikováno v:
Journal of Market Access & Health Policy, Vol 9, Iss 1 (2021)
Background: Evidence suggests that triple therapy for patients with chronic obstructive pulmonary disease (COPD) is being used in a broader range of patients than recommended by guidelines, which may have health and cost implications. Objective: To e
Externí odkaz:
https://doaj.org/article/4d8762b3aee14aebab792d1e652fad73
Autor:
Jinoos Yazdany, Xia Wang, Edward Hammond, Barnabas Desta, Nick Pooley, Julia Langham, Lindsay Nicholson, Sue Langham, Nina Embleton, Volkan Barut
Publikováno v:
RMD Open, Vol 6, Iss 2 (2020)
Objective To evaluate the risk of stroke and myocardial infarction (MI) in adult patients with systemic lupus erythematosus (SLE) through a systematic review and meta-analysis.Methods We searched MEDLINE and EMBASE from inception to May 2020 to ident
Externí odkaz:
https://doaj.org/article/9ddb606f2edb46b3bd4bc1eb094be2bd
Autor:
Sanjay Sethi, Antony Wright, Elisabeth Sophia Hartgers-Gubbels, Marlene Hechtner, Brendan Clark, Ciara Wright, Sue Langham, Roland Buhl
Publikováno v:
International journal of chronic obstructive pulmonary disease. 17
Sanjay Sethi,1 Antony Wright,2 Elisabeth Sophia Hartgers-Gubbels,3 Marlene Hechtner,3 Brendan Clark,4 Ciara Wright,2 Sue Langham,2 Roland Buhl5 1Pulmonary/Critical Care/Sleep Medicine, University at Buffalo, State University of New York, Buffalo, NY,
Autor:
Antony Wright, Helene Vioix, Shamika de Silva, Sue Langham, Jennifer Cook, Toby Capstick, Jennifer K Quint
Publikováno v:
BMJ Open. 12:e059158
ObjectivesThe objective of this study was to model the clinical and economic impact of adapting current clinical practice in the management of patients with chronic obstructive pulmonary disease (COPD) to treatment according to national and internati
Autor:
Philip Clarke, Edward C. F. Wilson, Deborah A. Marshall, Neil Hawkins, Tim Wrightson, Stirling Bryan, Mohsen Sadatsafavi, Sean Ekins, Anthony J. Hatswell, Renée J.G. Arnold, Will Sullivan, Sue Langham, Christopher Sampson
Publikováno v:
Pharmacoeconomics
Transparency in decision modelling is an evolving concept. Recently, discussion has moved from reporting standards to open source implementation of decision analytic models. However, in the debate about the supposed advantages and disadvantages of gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ba7a62ea96b8a6acd78c9e941ee54e
https://europepmc.org/articles/PMC8237575/
https://europepmc.org/articles/PMC8237575/